Review of overalp of Autism spectrum and schizophrenia, challenges to assessment, and a breif overview of CBT-p strategies modified for work with individuals who experience both autism spectrum concerns and psychosis presented on by Dr. Harry Sivec.
Review of overalp of Autism spectrum and schizophrenia, challenges to assessment, and a breif overview of CBT-p strategies modified for work with individuals who experience both autism spectrum concerns and psychosis presented on by Dr. Harry Sivec.
Research demonstrating how Acceptance and Commitment Therapy (ACTp) works within the Cognitive Behavioral Therapy for Psychosis (CBTp) program is presented by Valerie Kreider.
In this lecture, Dr. Dugan discusses the history of tobacco use and reviews the medications that may be effective for smoking cessation. By the end of this lecture, you will be able to: 1) identify pharmacologic targets for treatment of tobacco use disorder, 2) list the adverse effects seen with pharmacologic treatment of tobacco use disorder, and 3) compare the efficacy data for agents used for treatment of tobacco use disorder.
Findings on long-acting injectable antipsychotic medications are discussed by Dr. Doug Smith.
Dr. Smith discusses the most up-to-date information on the use of long-acting injectables for the treatment of psychosis in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Dr. Douglas Smith provides an update on COVID-19 and vaccination in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Dr. Sara Dugan discusses the mechanisms by which food and medication may interact. By the end of this lecture, you will be able to: 1) describe how food and drugs may interact, 2) list foods and medications that may result in interactions, and 3) identify steps to address food and drug interactions.
In this lecture, Dr. Dugan discusses medications that might be useful in treating schizoaffective disorder. By the end of this lecture, you will be able to: 1) describe the pharmacotherapeutic medications used for the treatment of schizoaffective disorder (SAD) and 2) compare the efficacy and safety data of different medications for the treatment of patients with SAD.
In this lecture, Dr. Dugan examines some of the potential therapeutic uses for amantadine, explains its mechanisms of action, and reviews potential risks. By the end of this lecture, you will be able to: 1) describe the mechanism of action of amantadine, 2) list the adverse effects associated with the use of amantadine, and 3) identify uses for amantadine in patients with mental health conditions.
In this lecture, Dr. Dugan explains how the MAO inhibitors work and the mechanisms behind the potential risks. She also discusses the therapeutic benefits of these medications and how to use them safely. By the end of this lecture, you will be able to: 1) describe the mechanism of action of the monoamine oxidase inhibitors (MAOIs), 2) identify relevant interactions of MAOIs with medications and foods, and 3) evaluate efficacy data of MAOIs in treatment of depression.
© 2024 Northeast Ohio Medical University | 4209 State Route 44, PO Box 95, Rootstown, Ohio 44272
ADA Compliance | Title IX | Privacy statement | Required document plugins